Clonixin is a non-steroidal anti-inflammatory drug (NSAID) with analgesic and anti-inflammatory properties, primarily used to relieve moderate pain such as headaches, dental pain, and musculoskeletal discomfort, and it belongs to the anthranilic acid derivative group, working by inhibiting prostaglandin synthesis to reduce pain and inflammation; it is commonly administered as clonixin lysinate, a more soluble form that allows faster absorption and a quicker onset of action, and its development dates back to the mid-20th century when researchers were seeking safer and more effective alternatives to traditional drugs like aspirin, after which it gained acceptance in regions such as Europe and Latin America, and although newer NSAIDs later dominated the global market, clonixin has continued to be used in certain areas due to its proven efficacy and reliability in short-term pain management, highlighting its lasting role in the evolution of analgesic therapy.
